Eagle Pharmaceuticals Inc (EGRX)
$0.65 $0.05 (8.50%) 4:37 PM 12/10/24
PINK | $USD | Drug Manufacturers - Specialty & GenericStock Data
-
Market Cap
$51.18M -
Day's Range
$0.65 - $0.65 -
Volume
468,255 -
52 Week Low / High
$3.21 - $15.70 -
PE Ratio
4.65x -
PEG Ratio
0.91 -
Dividend Frequency
-
EGRX's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 1
- Strong Buy
- 0
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $17.00
- Target Price
Company News
-
Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio — Jan 18th, 2024
Eagle Pharmaceuticals, Inc. WOODCLIFF LAKE, N.J., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today provided an update on its bendamustine intellectual property portfolio. On January 16, 2024, the United States Court of ...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$